Zusammenfassung
Hintergrund
Mit steigender Lebenserwartung steigt auch die Prävalenz der Arthrose relevant an. Der typische Patient mit operationsbedürftiger Osteoarthrose zwischen 65 und 75 Lebensjahren weist zu 20–25 % eine bisher unerkannte Osteoporose auf.
Fragestellung
Welcher Ablauf bietet sich für die Abklärung einer eventuellen Osteoporose präoperativ an? Welche Schlussfolgerungen werden für die operative Versorgung und die Nachbehandlung daraus gezogen?
Material und Methode
Die zur Verfügung stehende Literatur zur Erkrankungsprävalenz der Osteoporose, perioperativen Komplikationen bei Hüftendoprothesen, ausgewählte Registerinformationen, die Leitlinie zur Diagnostik und Therapie der Osteoporose sowie die einer angemessenen Nachbehandlung wurden in der vorliegenden Übersichtsarbeit zusammengefasst.
Ergebnisse
Die orthopädisch-osteologische Abklärung ermittelt das Frakturrisiko nach Hinweisen des DVO (Dachverband Osteologie) und der Beckenübersichtsaufnahme. Basierend auf der Risikoeinschätzung wird eine Empfehlung zur Implantatwahl und Verankerung gegeben. Wesentliche Risiken der operativen Versorgung einer Koxarthrose bei Osteoporose sind die intraoperative Fraktur und die kurzfristige aseptische Lockerung. In der Nachbehandlung sind ergänzend zur Endoprothesenschule eine suffiziente Sturzprophylaxe und dauerhafte Übungsbehandlung wichtig. Die Dauermedikation sollte auf Risikopräparate der PRISCUS-Liste überprüft werden. Das besondere kardiale Risikoprofil der NSAR (nichtsteroidale Antirheumatika) sollte berücksichtigt und für Patienten mit nachgewiesener Osteoporose eine antiresorptive Therapie eingeleitet werden.
Abstract
Background
With increasing life expectancy the prevalence of osteoarthritis is also substantially rising. Patients aged between 65 and 75 years scheduled for total joint arthroplasty suffer from undetected osteoporosis in 20–25 % of cases.
Objectives
How to determine osteoporosis during preoperative workup? Which conclusions can be drawn for the operation treatment and the postoperative course?
Methods
The literature dealing with the prevalence of osteoporosis, perioperative complications of total hip arthroplasty, selected register informations, guidelines for diagnostics and treatment of osteoporosis and for the postoperative treatment are summarized and discussed.
Results
The fracture risk is determined according to the guidelines of the Dachverband Osteologie (DVO, Governing Body on Osteology). The implant and the anchorage are selected based on the risk of suffering from osteoporosis. An intraoperative fracture and early aseptic loosening are the main operative risk factors. For the postoperative course in addition to education about arthroplasty, adequate support for prevention of falls is mandatory. Continuous physiotherapy with muscular strengthening is advisable. The long-term medication should be checked for risks in the PRISCUS list of potentially inappropriate medication in the elderly and non-steroidal anti-inflammatory drugs (NSAIDs) should not be prescribed in patients with cardiac comorbidities. Patients with confirmed osteoporosis should be treated with antiresorptive agents.
Literatur
Christensen K, Doblhammer G, Rau R, Vaupel JW (2009) Ageing populations: the challenges ahead. Lancet 374(9696):1196–1208
Gensichen J, Muth C, Butzlaff M et al (2006) Die Zukunft ist chronisch: das Chronic Care-Modell in der deutschen Primärversorgung Übergreifende Behandlungsprinzipien einer proaktiven Versorgung für chronische Kranke. Z Arztl Fortbild Qualitatssich 100:365–374
Robert Koch-Institut. Gesundheit in Deutschland aktuell 2010. Beiträge zur Gesundheitsberichterstattung des Bundes. 1. 2012. RKI, Berlin
Pogrund H, Rutenberg M, Makin M et al (1982) Osteoarthritis of the hip joint and osteoporosis: a radiological study in a random population sample in Jerusalem. Clin Orthop Relat Res 164:130–135
Makinen TJ, Alm JJ, Laine H et al (2007) The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone 40:1041–1047
Glowacki J, Hurwitz S, Thornhill TS et al (2003) Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg [Am] 85-A:2371–2377
Nawabi DH, Chin KF, Keen RW, Haddad FS (2010) Vitamin D deficiency in patients with osteoarthritis undergoing total hip replacement: a cause for concern? J Bone Joint Surg [Br] 92:496–499
Drees P, Decking J, Ghezel-Ahmadi V et al (2005) The common occurrence of osteoarthritis and osteoporosis and the value of markers of bone turnover. Z Rheumatol 64:488–498
Fuchs J, Rabenberg M, Scheidt-Nave C (2013) Prävalenz ausgewählter muskuloskelettaler Erkrankungen: Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:678–686
Hofbauer LC, Hamann C (2013) Deconstructing vitamin D deficiency. Sci Transl Med 5:193fs27
Jakob F (2007) Metabolische Knochenerkrankungen. Internist (Berl) 48:1101–1117
Robert Koch Institut (2013) Arthrose. Heft 54. 1–40. Berlin, Robert Koch Institut in Zusammenarbeit mit dem Statistischen Bundesamt
Sah AP, Thornhill TS, Leboff MS, Glowacki J (2007) Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int 18:1119–1126
Haussler B, Gothe H, Gol D et al (2007) Epidemiology, treatment and costs of osteoporosis in Germany – the BoneEVA study. Osteoporos Int 18:77–84
Kobayashi S, Saito N, Horiuchi H et al (2000) Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet 355(9214):1499–1504
Learmonth ID, Young C, Rorabeck C (2007) The operation of the century: total hip replacement. Lancet 370(9597):1508–1519
Mancuso CA, Ranawat CS, Esdaile JM et al (1996) Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys. J Arthroplasty 11:34–46
Hamel MB, Toth M, Legedza A, Rosen MP (2008) Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes. Arch Intern Med 168(13):1430–1440
Brummel-Smith K (1997) Geriatrics for orthopaedists. Instr Course Lect 46:409–416
Mak J, Wong E, Cameron I (2011) Australian and New Zealand Society for Geriatric Medicine. Position statement – orthogeriatric care. Australas J Ageing 30:162–169
Inouye SK, Zhang Y, Jones RN et al (2007) Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med 167:1406–1413
Postler A, Neidel J, Gunther KP, Kirschner S (2011) Incidence of early postoperative cognitive dysfunction and other adverse events in elderly patients undergoing elective total hip replacement (THR). Arch Gerontol Geriatr 53:328–333
Thiem U, Theile G, Junius-Walker U et al (2011) Prerequisites for a new health care model for elderly people with multimorbidity: the PRISCUS research consortium. Z Gerontol Geriatr 44:115–120
Boyd CM, Darer J, Boult C et al (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294:716–724
Bhala N, Emberson J, Merhi A et al (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769–779
DVO (2014) DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen. DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen [cited 13 A.D. Feb 21];304–324. http://www.dv-osteologie.org/uploads/Leitlinie%202009/DVO-Leitlinie%202009 %20Langfassung_Druck.pdf
Dorr LD, Faugere MC, Mackel AM et al (1993) Structural and cellular assessment of bone quality of proximal femur. Bone 14:231–242
Huber F (1994) Rehabilitation des geriatrischen Patienten. Orthopade 23:60–64
Bourne RB, Rorabeck CH, Ghazal ME, Lee MH (1994) Pain in the thigh following total hip replacement with a porous-coated anatomic prosthesis for osteoarthrosis. A five-year follow-up study. J Bone Joint Surg [Am] 76(10):1464–1470
Kinov P, Radl R, Zacherl M et al (2007) Correlation between thigh pain and radiological findings with a proximally porous-coated stem. Acta Orthop Belg 73:618–624
Raja SN, Haythornthwaite JA (1999) Anesthetic management of the elderly: measuring function beyond the immediate perioperative horizon. Anesthesiology 91:909–911
Holt S, Schmiedl S, Thurmann PA (2010) Potenziell inadäquate Medikation für ältere Menschen: Die PRISCUS-Liste. Dtsch Arztebl Int 107:543–551
Fitzgerald RH Jr, Brindley GW, Kavanagh BF (1988) The uncemented total hip arthroplasty. Intraoperative femoral fractures. Clin Orthop Relat Res 235:61–66
Davidson D, Pike J, Garbuz D et al (2008) Intraoperative periprosthetic fractures during total hip arthroplasty. Evaluation and management. J Bone Joint Surg [Am] 90:2000–2012
Sharkey PF, Hozack WJ, Callaghan JJ et al (1999) Acetabular fracture associated with cementless acetabular component insertion: a report of 13 cases. J Arthroplasty 14:426–431
Jasty M, Henshaw RM, O’Connor DO, Harris WH (1993) High assembly strains and femoral fractures produced during insertion of uncemented femoral components. A cadaver study. J Arthroplasty 8:479–487
Pritchett JW (2001) Fracture of the greater trochanter after hip replacement. Clin Orthop Relat Res 390:221–226
Parvizi J, Holiday AD, Ereth MH, LeWallen DG (1999) The Frank Stinchfield Award. Sudden death during primary hip arthroplasty. Clin Orthop Relat Res 369:39–48
Parvizi J, Johnson BG, Rowland C et al (2001) Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg [Am] 83-A:1524–1528
Hunt LP, Ben-Shlomo Y, Clark EM et al (2013) 90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 382(9898):1097–1104
Clohisy JC, Calvert G, Tull F et al (2004) Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res 429:188–192
Toossi N, Adeli B, Timperley AJ et al (2013) Acetabular components in total hip arthroplasty: is there evidence that cementless fixation is better? J Bone Joint Surg [Am] 95:168–174
Prokopetz JJ, Losina E, Bliss RL et al (2012) Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord 13:251
Kärrholm J, Garellick G, Herberts P, Rogmark C (2013) Build up and clinical relevance of the Swedish hip arthroplasty register. HIS Meeting 2012 Zürich, oral presentation
Makela KT, Eskelinen A, Pulkkinen P et al (2008) Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg [Am] 90:2160–2170
Hailer NP, Garellick G, Karrholm J (2010) Uncemented and cemented primary total hip arthroplasty in the Swedish hip arthroplasty register. Acta Orthop 81:34–41
Bourne RB, Rorabeck CH (1998) A critical look at cementless stems. Taper designs and when to use alternatives. Clin Orthop Relat Res 355:212–223
Barrack RL (2000) Early failure of modern cemented stems. J Arthroplasty 15:1036–1050
Anand R, Graves SE, Steiger RN de et al (2011) What is the benefit of introducing new hip and knee prostheses? J Bone Joint Surg [Am] 93(Suppl 3):51–54
Learmonth ID (2005) Conservative hip implants. Curr Orthop 19:255–262
Westphal FM, Bishop N, Honl M et al (2006) Migration and cyclic motion of a new short-stemmed hip prosthesis – a biomechanical in vitro study. Clin Biomech (Bristol, Avon) 21:834–840
Bishop NE, Burton A, Maheson M, Morlock MM (2010) Biomechanics of short hip endoprostheses – the risk of bone failure increases with decreasing implant size. Clin Biomech (Bristol, Avon) 25:666–674
Kim YH, Park JW, Kim JS (2013) Is diaphyseal stem fixation necessary for primary total hip arthroplasty in patients with osteoporotic bone (class C bone)? J Arthroplasty 28:139–146
Pivec R, Johnson AJ, Mears SC, Mont MA (2012) Hip arthroplasty. Lancet 380(9855):1768–1777
Leonardsson O, Garellick G, Karrholm J et al (2012) Changes in implant choice and surgical technique for hemiarthroplasty. 21,346 procedures from the Swedish Hip Arthroplasty Register 2005–2009. Acta Orthop 83:7–13
Heisel J, Jerosch J (2007) Die Endoprothesenschule. Deutscher Ärzte-Verlag, Köln
Becker C, Cameron ID, Klenk J et al (2011) Reduction of femoral fractures in long-term care facilities: the Bavarian fracture prevention study. PLoS One 6:e24311
Hauer K, Specht N, Schuler M et al (2002) Intensive physical training in geriatric patients after severe falls and hip surgery. Age Ageing 31:49–57
Cameron ID, Gillespie LD, Robertson MC et al (2012) Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 12:CD005465
Felsenberg D, Dietzel R (2008) Leitlinie Physiotherapie bei Osteoporose. http://www.dv-osteologie.org/uploads/Leitlinie%20Physiotherapie/Langfassung_Physiotherapie-Leitlinie.pdf. 1–92. DVO. 3-10-2013
RAND Cooperation. Evidence report and evidence-based recommendations (2003) Exercise programs for older adults: a systematic review and meta-analysis. http://www rand org/pubs/reprints/RP1257 html [cited 2013 Oct 5];1–134. http://www.rand.org/pubs/reprints/RP1257.html
Becker C, Rapp K (2011) Stürze in der Geriatrie Diagnostik und Therapie. Internist (Berl) 52:939–945
Fransen M, Neal B (2013) WITHDRAWN: non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 3:CD001160
Vavken P, Castellani L, Sculco TP (2009) Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res 467:3283–3289
Bischoff-Ferrari H, Stahelin HB, Walter P (2011) Vitamin D effects on bone and muscle. Int J Vitam Nutr Res 81:264–272
Bischoff-Ferrari HA, Conzelmann M, Stahelin HB et al (2006) Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 17:656–663
Zhu L, Zheng W, Zhao FC et al (2013) A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty. J Orthop Sci 18:762–773
Lin T, Yan SG, Cai XZ, Ying ZM (2012) Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporos Int 23:1823–1834
Iwamoto N, Inaba Y, Kobayashi N et al (2011) A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty. J Bone Joint Surg [Am] 93:1203–1209
Skoldenberg OG, Salemyr MO, Boden HS et al (2011) The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg [Am] 93:1857–1864
Muratore M, Quarta E, Quarta L et al (2012) Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab 9:50–55
Scott DF, Woltz JN, Smith RR (2013) Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial. J Arthroplasty 28:671–675
Prieto-Alhambra D, Javaid MK, Judge A et al (2011) Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 343:d7222
Thillemann TM, Pedersen AB, Mehnert F et al (2010) Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone 46:946–951
Sambrook PN, Cameron ID, Chen JS et al (2011) Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Osteoporos Int 22:2551–2556
Einhaltung ethischer Richtlinien
Interessenkonflikt. S. Kirschner, A. Hartmann, K.-P. Günther, C. Hamann geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirschner, S., Hartmann, A., Günther, KP. et al. Endoprothetische Versorgung bei osteoporoseassoziierter Koxarthrose. Orthopäde 43, 353–364 (2014). https://doi.org/10.1007/s00132-013-2167-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00132-013-2167-0